Area of research
Molecular Biology · Clinical Psychology
Research interest
Research interests include Prion Diseases and Protein Misfolding, Psychoanalysis and Psychopathology Research, Neurological diseases and metabolism, and Alzheimer's disease research and treatments.
Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study
POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study.
A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease.
The neurobehavioral effects of the designer drug naphyrone - an experimental investigation with pharmacokinetics and concentration/effect relationship in mice.
Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients.
International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in <i>STX6</i> and <i>GAL3ST1</i>
Age at onset in genetic prion disease and the design of preventive clinical trials
Age at onset in genetic prion disease and the design of preventive clinical trials.
Selecting reference genes in RT-qPCR based on equivalence tests: a network based approach.
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease.
Autosomal recessive Treacher Collins syndrome due to POLR1C mutations: Report of a new family and review of the literature.
Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.
Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
QT length during methadone maintenance treatment: gene × dose interaction.
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.
Amplification techniques and diagnosis of prion diseases.
Determination of sets of covariating gene expression using graph analysis on pairwise expression ratios.
Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.
Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study.
Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships.
Gene-Gene interactions and pleiotropy in the brain nicotinic pathway associated with the heaviness and precocity of tobacco smoking among outpatients with multiple substance use disorders
Quantifying prion disease penetrance using large population control cohorts